CR7203A - 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1 - Google Patents

5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1

Info

Publication number
CR7203A
CR7203A CR7203A CR7203A CR7203A CR 7203 A CR7203 A CR 7203A CR 7203 A CR7203 A CR 7203A CR 7203 A CR7203 A CR 7203A CR 7203 A CR7203 A CR 7203A
Authority
CR
Costa Rica
Prior art keywords
modulators
arilpiridinas
substitutes
disorders
release factor
Prior art date
Application number
CR7203A
Other languages
Spanish (es)
Inventor
Ge Ping
Yoon Taeyoung
Yan Zhang Lu
F Horvath Raynibd
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Priority to CR7203A priority Critical patent/CR7203A/en
Publication of CR7203A publication Critical patent/CR7203A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Estos compuestos pueden actuar como moduladores selectivos de receptores de CRF. Los compuestos de 5-sustituidas-2-arilpiridinas proporcionados son utiles en el tratamiento de varios trastornos de sistema nervioso central y periferico, de manera particular, tension nerviosa, ansiedad, depresion, trastornos cardiovasculares, y trastornos de alimentacion. Se proporciona un metodo de tratamiento de estos trastornos y tambien como composiciones farmaceuticas envasadas.These compounds can act as selective modulators of CRF receptors. The 5-substituted-2-arylpyridine compounds provided are useful in the treatment of various disorders of the central and peripheral nervous system, in particular, nervous tension, anxiety, depression, cardiovascular disorders, and eating disorders. A method of treatment of these disorders and also as packaged pharmaceutical compositions is provided.

CR7203A 2003-12-15 2003-12-15 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1 CR7203A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CR7203A CR7203A (en) 2003-12-15 2003-12-15 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CR7203A CR7203A (en) 2003-12-15 2003-12-15 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1

Publications (1)

Publication Number Publication Date
CR7203A true CR7203A (en) 2004-02-23

Family

ID=44839148

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7203A CR7203A (en) 2003-12-15 2003-12-15 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1

Country Status (1)

Country Link
CR (1) CR7203A (en)
  • 2003

Similar Documents

Publication Publication Date Title
UY28150A1 (en) THERAPEUTIC AGENTS
ECSP034898A (en) 2,5-DIARILPIRAZINAS, 2,5-DIARILPIRIDINAS and 2,5- DIARILPIRIMIDINAS
GT200600159A (en) BENZODIOXAN AND BENZODIOXOLAN DERIVATIVES AND USES OF THE SAME
CR6698A (en) CORTICOTROPINE RELEASE FACTOR ANTAGONISTS
ECSP045392A (en) MODULATORS TETRAHIDROPIRANIL-CICLOPENTIL-TETRAHIDROPIRIDOPIRIDINICOS OF THE ACTIVITY OF CHEMIOKIN RECEPTORS
CR9834A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF EZQUIZOPHRENIA
ES2127946T3 (en) DIAZABYCLIC NEUROCININE ANTAGONISTS.
AR091405A2 (en) OMEGA-CARBOXIARIL DIFENIL UREA REPLACED WITH FLUORO AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE60107687D1 (en) CYCLPENTANOINDOLE, MIXTURES CONTAINING SUCH COMPOUNDS AND TREATMENT METHODS
PA8631301A1 (en) MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
PA8615701A1 (en) DERIVATIVES OF DIHYDROBENZOFURANYL ALCANAMINE AND METHODS FOR USE.
CR20110095A (en) BICYCLE DERIVATIVES [3.1.0] AS INHIBITORS OF THE GLYCINE CONVEYOR (DIVISIONAL APPLICATION 8333)
NI200700056A (en) NEW DERIVATIVES OF SULFAMIDS OF HETEROARIL BENZO-FUNDIDO USEFUL AS ANTI-CONVERSION AGENTS
AR028824A1 (en) NPY-5 ANTAGONIST COMPOUNDS AND ITS USE IN THE MANUFACTURE OF MEDICINES.
DE602004018494D1 (en) FLUVASTATIN SODIUM IN CRYSTAL FORM XIV, METHOD FOR THE PRODUCTION THEREOF, COMPOSITIONS COMPRISING THIS AND CORRESPONDING METHOD OF USE
GT200300263A (en) INDAZOL DERIVATIVES AS CRF ANTAGONISTS
ECSP034860A (en) 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1
CY1109808T1 (en) ARYLYNDEO-PYRIDINES AND ARYLYNDEO-PYRIDYNES AND THEIR USE AS COMPETITORS OF ADENOSIN A2A RECEPTORS
UY26924A1 (en) PHENOXIBENCILAMINE DERIVATIVES AS SSRI
ECSP066716A (en) TAQUIQUININE HYDROISOINDOLINE RECEIVER ANTAGONISTS
ATE457309T1 (en) MODULATORS OF PERIPHERAL 5-HT RECEPTORS
CR7203A (en) 5-SUBSTITUTES-2-ARILPIRIDINAS AS MODULATORS OF CORTICOTROPINE RELEASE FACTOR 1
ATE384066T1 (en) THIENO-PYRROLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN-REleasing HORMONE RECEPTORS
DE602007012531D1 (en) AZABICYCLOA3.1.0 OXIDE DERIVATIVES AS MODULATORS OF DOPAMINE D3 RECEPTORS
CR7735A (en) HETEROCICLIC PIPERIZINES REPLACED FOR THE TREATMENT OF CHICHOPHRENIA

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)